Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diphenylamine SCHEMBL27959134 | 0.88 | MAPT (0.58) | TSHRALDH1A1CYP1A2SMN1; SMN2TDP1 | |
| Trichloroacetic Acid SCHEMBL6599928 | 0.85 | TSHR (0.50) | TSHRALDH1A1CYP1A2TP53SMN1; SMN2 | |
| Benzidine SCHEMBL11743215 | 0.83 | ALDH1A1 (0.52) | TSHRALDH1A1CYP1A2TP53SMN1; SMN2 | |
| Aniline SCHEMBL8413315 | 0.81 | TSHR (0.73) | TSHRALDH1A1CYP1A2PBRM1TDP1 | |
| Aniline SCHEMBL28088182 | 0.81 | TSHR (0.73) | TSHRALDH1A1CYP1A2SMN1; SMN2TDP1 | |
| Aniline SCHEMBL6049858 | 0.81 | TSHR (0.73) | TSHRALDH1A1CYP1A2PBRM1TDP1 | |
| Aniline SCHEMBL3769652 | 0.80 | TSHR (0.55) | TSHRCYP1A2SMN1; SMN2HIF1APBRM1 | |
| Dalfampridine SCHEMBL11585366 | 0.79 | ALDH1A1 (0.56) | TSHRALDH1A1CYP1A2TP53SMN1; SMN2 | |
| Trichloroacetic Acid SCHEMBL7743410 | 0.79 | ACHE (0.56) | TSHRALDH1A1CYP1A2TP53SMN1; SMN2 | |
| Aniline SCHEMBL4894770 | 0.78 | TSHR (0.69) | TSHRALDH1A1CYP1A2PBRM1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002020544-A1 | PROCESS FOR PREPARING PEPTIDE DERIVATIZED OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| EP-1181301-A1 | OLIGONUCLEOTIDE SYNTHESIS WITH LEWIS ACIDS AS ACTIVATORS | ABBOTT LABORATORIES (US) | 2002-02-27 | — | — | EP | disclosed |
| EP-1165575-A1 | PHOSPHATE CONTAINING MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000075157-A1 | OLIGONUCLEOTIDE SYNTHESIS WITH LEWIS ACIDS AS ACTIVATORS | ABBOTT LABORATORIES (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-2000058318-A1 | PHOSPHATE CONTAINING MACROCYCLIC IMMUNOMODULATORS | ABBOTT LABORATORIES (US) | 2000-10-05 | — | — | WO | disclosed |
| US-5574146-A | Oligonucleotide synthesis with substituted aryl carboxylic acids as activators | BECKMAN INSTRUMENTS, INC. (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0725787-A1 | ACTIVATED NUCLEOSIDE PHOSPHORAMIDITES AND METHODS FOR THE PREPARATION AND USE THEREOF | BECKMAN INSTRUMENTS, INC. (US) | 1996-08-14 | — | — | EP | disclosed |
| WO-1996006853-A1 | ACTIVATED NUCLEOSIDE PHOSPHORAMIDITES AND METHODS FOR THE PREPARATION AND USE THEREOF | BECKMAN INSTRUMENTS, INC. (US) | 1996-03-07 | — | — | WO | disclosed |
| EP-0003263-B1 | A METHOD OF FORMING AN IMAGE, AND AN IMAGING ELEMENT FOR INHIBITING IMAGE FORMATION WITH COBALT (III) COMPLEXES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4273860-A | INCLUDING A PHOTOINHIBITOR TO SUPPRESS DECOMPOSITION OF THE COBALT COMPLEX USING RADIATION OF WAVELENGTHS LONGER THAN 300NM; NEGATIVES AND POSITIVES | EASTMAN KODAK COMPANY (US) | 1981-06-16 | — | — | US | disclosed |
| EP-0003263-A1 | A method of forming an image, and an imaging element for inhibiting image formation with cobalt (III) complexes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1979-08-08 | — | — | EP | disclosed |
| WO-1979000448-A1 | INHIBITING IMAGE FORMATION WITH COBALT(III)COMPLEXES | EASTMAN KODAK CO (US) | 1979-07-26 | — | — | WO | disclosed |